About Michael Petit
Michael Petit is a director at General Oncology.
Michael Petit first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Petit in the role, so the role may have started earlier or lasted longer.
General Oncology, Inc.
Director
2020 – 2026 · Newton, MA
Develops experimental treatments for people with metastatic cancer and other proliferative diseases.
Key Colleagues at Startups
The people Michael Petit works with at each company, as listed on that company's latest Form D.
General Oncology, Inc. · Form D, Apr 23, 2026
BS
Barry Seeman
Director
AG
Arnold Glazier
Chief Scientific Officer and director
JG
Jeffrey Glazier
Chief Executive Officer and director
AA
Abid Ansari
Chief Financial Officer